Illumina to Submit Cytogenetics Package to FDA, Commits to Using Arrays in Dx

The decision marks a shift in strategy for Illumina, which had previously positioned its digital microbead-based BeadXpress reader as its diagnostics platform of choice. Now it will seek FDA clearance for clinical use of its arrays, too.